Suicide Gene Therapy By Amphiphilic Copolymer Nanocarrier for Spinal Cord Tumor

The Value of DTI Parameters in Predicting Postoperative Spinal Cord Function Fluctuations in Patients with High Cervical Disc Tumors

Objective

To explore the characteristics of magnetic resonance diffusion tensor imaging (DTI) parameters in patients with high cervical spinal myeloma and the evaluation of postoperative spinal cord function.

Methods

In recent years, 42 patients with high cervical spine myeloma were selected as the observation group, and 42 healthy volunteers were selected as the control group during the same period. The apparent dispersion coefficient (ADC), the fractional anisotropy (FA), the number of fiber bundles (FT), and the fiber bundle ratio (FTR) were compared between the two groups. The correlation between the ADC, FA, FT, FTR, and the International Standard for Neurological Classification of Spinal Cord Injury (ISNCSCI) score in the observation group were analyzed. Spinal cord function was evaluated using the Japanese Orthopaedic Association Score (JOA). Logistic regression model was used to analyze the factors affecting the recovery of spinal cord function after surgery. The receiver operating characteristic curve (ROC) was used to analyze the value of ADC, FA, FT, FTR1, and FTR2 in predicting the recovery of spinal cord function.

Results

The ADCs of the lesion layer and lower layer of the observation group were higher than the middle and lower layers of the control group, the FA and FT were lower than the middle and lower layers of the control group, and FTR1 and FTR2 were lower than those of the control group (P < 0.05). The ADC of the lesion layer in the observation group was negatively correlated with ISNCSCI score, and the FA, FT, FTR1, FTR2, and ISNCSCI scores were positively correlated (P < 0.05). Three months after the operation, JOA was used to evaluate the spinal cord function, which was excellent in 23 cases and poor in 19 cases. Logistic regression model analysis showed that after the ISNCSCI score was controlled, the increase in ADC and the decrease in FA, FT, FTR1, and FTR2 of the lesion layer were independent risk factors for poor postoperative body function recovery (P < 0.05). ROC analysis showed that the combination of ADC, FA, FT, FTR1, and FTR2 of the lesion layer predicted the AUC of spinal cord functional recovery was 0.941, which was better than the single prediction (P < 0.05).

Conclusion

The abnormal DTI parameter values of patients with high cervical spinal myeloma can better reflect the lack of spinal cord function, and they can effectively predict the recovery of the patient's body function after surgery, providing a reference for clinical diagnosis and treatment.

The role of gene therapy as a valuable treatment modality for multiple spinal pathologies

The world of biomedical research has led to several breakthroughs in the treatment of various spinal pathologies. As we investigate chronic pathologies of the spine, we start to unravel the underlying molecular mechanisms through a careful analysis of mutated genetic sequences. Investigations have led to gene therapy being explored for its potential as a treatment modality. Despite only about 2% of current gene therapy trials being centered for spinal pathologies, spinal diseases are valuable targets in gene therapy administration. Through a comprehensive literature review, our objective is to discuss the molecular mechanisms behind gene therapy for spinal pathologies, the genetic targets, along with the outcomes, success, and possible pitfalls in gene therapy research and administration. The emerging development of robotic technologies and intelligent carriers are recognized as a promising innovative technique for increasing the efficiency of gene therapy and potentially resolving spinal pathologies.

Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma

Uterine leiomyoma (UL) is one of the most common benign tumors in women that often leads to many reproductive complications. Suicide genetherapy was suggested as a promising approach for UL treatment. In the present study, we describe iRGD ligand-conjugated cysteine-rich peptide carrier RGD1-R6 for targeted DNA delivery to αvβ3 integrin-expressing primary UL cells. The physico-chemical properties, cytotoxicity, transfection efficiency and specificity of DNA/RGD1-R6 polyplexes were investigated. TheHSV-1thymidine kinase encoding plasmid delivery to PANC-1pancreatic carcinoma cells and primary UL cells resulted in significant suicide gene therapy effects. Subsequent ganciclovir treatment decreased cells proliferative activity, induced of apoptosis and promoted cells death.The obtained results allow us to concludethatthe developed RGD1-R6 carrier can be considered a promising candidate for suicide gene therapy of uterine leiomyoma.

Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor

PURPOSE

Malignant gliomas are aggressive spinal cord tumors. In this study, we hypothesized that combination therapy using an anti-angiogenic agent, bevacizumab, and hypoxia-inducible glioblastoma-specific suicide gene could reduce tumor growth.

MATERIALS AND METHODS

In the present study, we evaluated the effect of combination therapy using bevacizumab and pEpo-NI2-SV-TK in reducing the proliferation of C6 cells and tumor growth in the spinal cord. Spinal cord tumor was generated by the injection of C6 cells into the T5 level of the spinal cord. Complexes of branched polyethylenimine (bPEI)/pEpo-NI2-SV-TK were injected into the spinal cord tumor. Bevacizumab was then administered by an intraperitoneal injection at a dose of 7 mg/kg. The anti-cancer effects of combination therapy were analyzed by histological analyses and magnetic resonance imaging (MRI). The Basso, Beattie and Bresnahan scale scores for all of the treatment groups were recorded every other day for 15 days to assess the rat hind-limb strength.

RESULTS

The complexes of bPEI/pEpo-NI2-SV-TK inhibited the viability of C6 cells in the hypoxia condition at 5 days after treatment with ganciclovir. Bevacizumab was decreased in the cell viability of human umbilical vein endothelial cells. Combination therapy reduced the tumor size by histological analyses and MRI. The combination therapy group showed improved hind-limb function compared to the other groups that were administered pEpo-NI2-SV-TK alone or bevacizumab alone.

CONCLUSION

This study suggests that combination therapy using bevacizumab with the pEpo-NI2-SV-TK therapeutic gene could be useful for increasing its therapeutic benefits for intramedullary spinal cord tumors.

Polymeric vehicles for nucleic acid delivery

Polymeric vehicles are versatile tools for therapeutic gene delivery. Many polymers-when assembled with nucleic acids into vehicles-can protect the cargo from degradation and clearance in vivo, and facilitate its transport into intracellular compartments. Design options in polymer synthesis yield a comprehensive range of molecules and resulting vehicle formulations. These properties can be manipulated to achieve stronger association with nucleic acid cargo and cells, improved endosomal escape, or sustained delivery depending on the application. Here, we describe current approaches for polymer use and related strategies for gene delivery in preclinical and clinical applications. Polymer vehicles delivering genetic material have already achieved significant therapeutic endpoints in vitro and in animal models. From our perspective, with preclincal assays that better mimic the in vivo environment, improved strategies for target specificity, and scalable techniques for polymer synthesis, the impact of this therapeutic approach will continue to expand.